Bristol-Myers Squibb (BMY): Cramer’s Old-School Move for DeepSeek Market Jitters
We recently published a list of Jim Cramer Breaks Silence On DeepSeek AI Sell-Off & Discusses These 12 Stocks. In this ...
Jim Cramer Says Bristol-Myers Squibb Company (BMY)’s ‘Got The One That Everybody Is Buzzing About’
We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...
NBC New York14d
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
But Alzheimer's is the "really large market here," Bristol Myers Squibb CFO David Elkins told CNBC on Tuesday at the JPMorgan Health Care Conference in San Francisco. There are nearly 6 million ...
Business Insider15d
Bristol Myers CEO says new drug Cobenfy effective in schizophrenia, CNBC reports
Bristol Myers (BMY) new psychiatric drug Cobenfy is effective in treating schizophrenia without “the serious side effects’ of other older therapies, writes Julie Coleman for CNBC..Bristol ...
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer’s-related psychosis during the ...